Luis A. Quiñones
1
Fujun Han
2*
Ye Guo
3*The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Oncol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1442630
This article is part of the Research Topic Precision Therapy and Biomarkers in Head and Neck Squamous Cell Carcinoma View all 6 articles
Editorial: Precision Therapy and Biomarkers in Head and Neck Squamous Cell Carcinoma
Provisionally accepted- 1 Faculty of Medicine, University of Chile, Santiago, Santiago Metropolitan Region (RM), Chile
- 2 Cancer Center, The First Hospital of Jilin University, Changchun, China
- 3 Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, Shanghai Municipality, China
Keywords: biomarker, epidermal growth factor receptor, Head and neck squamous cell carcinoma, Immune checkpoint inhibitor, precision therapy
Received: 02 Jun 2024; Accepted: 01 Jul 2024.
Copyright: © 2024 Quiñones, Han and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fujun Han, Cancer Center, The First Hospital of Jilin University, Changchun, China
Ye Guo, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, Shanghai Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.